Bermoprofen
CAS No. 78499-27-1
Bermoprofen( —— )
Catalog No. M33287 CAS No. 78499-27-1
Bermoprofen (AD-1590) is an orally active non-steroidal anti-inflammatory compound with analgesic properties, utilized in gastric ulcer studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 282 | In Stock |
|
| 10MG | 471 | In Stock |
|
| 25MG | 943 | In Stock |
|
| 50MG | 1237 | In Stock |
|
| 100MG | 1655 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBermoprofen
-
NoteResearch use only, not for human use.
-
Brief DescriptionBermoprofen (AD-1590) is an orally active non-steroidal anti-inflammatory compound with analgesic properties, utilized in gastric ulcer studies.
-
DescriptionBermoprofen (AD-1590) is an orally active non-steroidal anti-inflammatory agent. Bermoprofen has potent antipyretic activities with a short biological half-life. Bermoprofen is a potent antagonist of LPS-induced fever in rabbits.
-
In VitroBermoprofen (AD-1590) shows ulcerogenic activity as a side-effect like other nonsteroidal anti-inflammatory agents.
-
In VivoBermoprofen (AD-1590) (0.04-0.1 mg/kg; p.o.) shows a dose-related antipyretic activity in LPS-induced febrile rabbits.Animal Model:Male albino rabbits, 2.3-3 kg Dosage:0.04, 0.4, 0.1 mg/kg Administration:Oral; given 1 h after i.v. injection of LPS Result:Inhibited significantly the rise in rectal temperature at doses of 0.1 mg/kg or more, the temperature returned approximately to normal after 0.4 mg/kg.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number78499-27-1
-
Formula Weight296.32
-
Molecular FormulaC18H16O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (337.47 mM; Ultrasonic )
-
SMILESO=C(O)C(C1=CC=C2OC3=CC=C(C=C3CC(=O)C2=C1)C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mori M, et al. Prolongation of antipyretic action and reduction of gastric ulcerogenicity in the rat by controlled-release granules of bermoprofen, a new nonsteroidal anti-inflammatory drug. J Pharm Sci. 1991 Sep;80(9):876-80.?
molnova catalog
related products
-
EMD638683
EMD638683a novel SGK inhibitor with antihypertensive potency(with an IC50 of 3 μM).
-
JG-2016
JG-2016, as a small molecule histone acetyltransferase 1 (HAT1) inhibitor, inhibits the growth of human cancer cell lines, inhibits enzyme activity in cellulose, and interferes with tumor growth.
-
JAMM protein inhibit...
JAMM protein inhibitor 2?is an inhibitor of JAMM protease and can be used for anticancer studies. The IC50s are 10 μM, 46 μM, and 89 μM for thrombin, Rpn11, and MMP2, respectively.
Cart
sales@molnova.com